Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree Ziggy about the patent of A 2-73 plus. So Rhett may get us to market the fastest and then Alz trial with the results of A 2-73 plus patent comes into play with "pooled data". Why promote monotherapy when we can pool the data for a MONSTER patent. Then the companies resources can be freed up to run what, maybe some heart disease trials, insomnia etc? Also the A3-71 orphan designation trials will be moved up the list with upfront payments from partnership. We were also invited to speak at the recent roundtable for non-opiod pain management with A 1066 so the good Dr. is laying a very broad foundation for either a VERY healthy partnership or a larger ship!
This recent partnership with Ariana IMO is here to stay and if we can stay independent from takeover I see this company continuing to run MULTIPLE, very efficient trials through partnerships with organizations. We are talking about reaching 10's BILLIONS, through further validation in other indications, of revenue with in a decade.
HE is meticulously crafting a BIGGER SHIP!
Tred
This is the next 5 PR's I see happening:
1) Patent of A 273 plus
2)PArtnership with ___ge_
3)Start of phase 2/3
4)Rhett syndrome phase 2 funding
5) MS trial update.
Any of these will start the clock ticking for the shorts!
Tred
Could it be that the delay in the Dr. heavily promoting is patent issues? I think they are close to working out the details on the patent with the FDA but as some here have put it, we ARE going to "need a bigger boat". Why get the cart ahead of the horse. With the FDA guiding Anavex on a phase 2/3, remote possibility (but still a chance) of Accelerated approval leading to approval about 6 months into(?) a phase 3, wouldn't you want the patent and partnershipto be aligned?
Tred
Thanks again Neiu! Its like Dr. Missling is at the helm of a mile long train, of extremely important cargo (drugs) , with 6-7 main engines (drug trials)! While it takes some time to get the train moving, once it starts moving (with trial starts)it will not stop! Wow! When will Ariana's data start to surface helping to ACCELERATE this drug to market?
Look out shorts! That whistle you hear in the distant isn't always what it appears. Big things do come in SMALL packages and while this ALZ trial may take a year or more, Rhetts, (possibly) Parkinsons, and Infantile spasms will not! EVERY trials data continues to SUPPORT the HOMEOSTASIS that is happening in the brain.
chug-a, chug-a, chug-a, CHOO! CHOOOOOO!
Tred
As I scrolled through Ariana's website I happened to look at who they were partnered with and one name stood out in particular,...Sanofi. Where did I see that name before? Ahh yes that was where Dr. Missling worked at before joining Anavex. They are listed in the "Personalized Cancer Treatment" section of "Industrialized Partners".
While this might not mean much now, I believe Ariana is HERE TO STAY as we rapidly apply their technology to the unfolding of "...many phase 2/3 trials up and running in 2017"(paraphrase)
http://www.arianapharma.com/portfolio/imodi/
This was also of interest on their page:
(underline added by me for emphasis)
An integrated solution
Using your data, Ariana combines baseline characteristics, gene expression, protein measurements, metabolomic data and any other relevant data you provide, and ranks each combination of these data points, showing you the most important to your trial.
We dig out more meaningful relationships than other approaches, without relying on outside databases, or resorting to “data fitting” as is too common.
Better patient response
Knowing the attributes that describe your best responders allows you to refine your Inclusion/Exclusion criteria as part of your Adaptive Trial, or for your next clinical phase of development.
Greater patient response rates reduces the number of patients needed to meet your endpoint.
Experience counts
Ariana has identified valuable and meaningful signatures in multiple clinical projects in cancer, neural diseases, rheumatology, ocular diseases, metabolic disease, childhood diseases, renal, anti-viral, anti-bacterial, among others.
We provide more than just data analysis, we help you see what others miss. (color added by me for emphasis)
http://www.arianapharma.com/services/clinical-data-analysis/
Just a little longer before the first horse is out of the gate!
HAPPY NEW YEAR!
Tred
Hess Thanks for posting that well organized compilation of the many potential future catalysts. JOB WELL DONE!
Tred
Good Morning All! A big thank you for the moderators of this board who have helped keep this board a civil place to follow and discuss Anavex as developments have occurred, EXTREMELY VALUABLE!
On another note does anyone know when we might hear about whether or not we have a piece of the "Cures Act" pie. Is is tied to or triggered by the trial starting that funding may have been allocated for? I am still holding out hope that this is the funding mechanism for Phase 2/3 for our Alzheimers trial. At the very least! With the latest roundtable and data delivered we may be looking at multiple trials with a funding source.
Good luck to all longs.
Tred
I seem to always forget to paste the link for some reason, a duh moment. The drug is called Rayaldee and is created by Opko Health.
http://investor.opko.com/releasedetail.cfm?ReleaseID=976439
Tred
Plex, the speed with which I see Missling lining up these trials, for pennies on the dollar, through partnerships amazes me. He is getting into the right circles with respects to the Gov., drawing in top Phd's in fields of ALZ, PK, etc to his SAB. His methodical approach to "diversify" this drugs entrance into the market is remarkable.
On another note,I wonder if someone else might know whether or not any other company, in a phase 2a, has used the FDA's adaptive open label trial for AZ where we could compare the outcome. I believe the FDA came out in 2010 with this new approach of a trial to quicken failure or positive results. If not, than we are in uncharted waters with respects to the FDA (accelerated?)approval process, power of results, use of historical placebo data.
Regarding the 10 billion price tag, IF this were a one trick pony than that would be a valuation on the high side at this stage(one could even argue that with that Heptares deal), but being that we have MULTIPLE INDICATIONS that we are targeting, well than that very well in a year may be a lowball estimate!
GO ARIANA! GO AVXL!
Tred
Is a perfect storm brewing?
Missling states that a partnership would be 6-12 months out,....12 months ago.
Anavex retains some top of the line council some time ago. Perhaps when partnership negotiations started or just legal council for the bogus lawsuit??
Never before seen results at 31 weeks in ALZ trial.
BOD renews Misslings contract handsomely.
Multiple Phase 2 trials lining up to start in 2017.
"quiet period" is necessary due to partnership neg. This whole time we are waiting for partnership news and it may be that is "locked up" until what, Biogen test for MS proves positive?
NIH presentations,....Cures Act signed sealed and delivered!
Biogen signs MTA for MS, perhaps to round out the deal with anavex for MS, PArkinsons, Alz, Retts......
Ariana is working overtime to connect the dots in ALZ for, what proof for....FDA accelerated approval?
FDA is seeing the same data and more as patients have been on the drug for almost 2 years.
New Ceo comes in for Biogen who is talking about rapidly boosting pipeline.
MILLION DOLLAR QUESTION: Who gets to make the announcement? Missling or Biogen's new CEO about the.....wait for it.....1 share FOR 1 share partnership? That's only 10 billion. In 5 years that will be a drop in the bucket especially if Anavex announces Accelerated Approval for ALZ!
p.s. sorry for the slight rambling and that everything is not necessarily in chronological order. Ihub has been slow lately since that DDOS attack.
Tred
Todays the day Dr Missling should have a PR waiting in the wings.....like funding for phase 2/3 or something strong enough to put these idiots in check. HIT THEM IN THE WALLET I SAY!
TRED
I agree MC, while I was hoping for a bit more too I found myself being really impressed with all the points he made in the presentation. If not a partnership announcement in the wings maybe he is waiting on Obama to sign the Cures Act so he can CONFIRM and share the funding mechanism for at least one of the Phase 2/3 trials. In 2016 this company has grown leaps and bounds with respect to clinical trials and scientific validity. Its ALL THERE! Its just going to take a bit longer than everyone would like. Ariana is also still in the background diligently working combing through the results........any day, any week , any month!
Tred
How about a 1 for 1 deal with Biogen, and Missling becomes CEO with his current team in place. In 5 years with his leadership and AVXL's pipeline BIIB would be knocking on JNJ's door in size!
Id take it, nothing less.
Tred
Did the President sign the Cures Act yet? RELEASE THE HOUNDS! Over 3 billion in "brain" research! We HAVE to have been given a piece of that pie to cover our Ph2/3.
Tred
What are all these talks about 1-2 Billion? THERE IS NO WAY our Good Dr. is going to allow ANYONE to walk in and scoop this up, PERIOD! Heptares was was given a partnership for 3 billion for a phase 1b. I'm sure he is very familiar with ways in which he is able to ward off a buyout. Especially when we have been manipulated and hammered down to $3! we should be at atleast $8-10 and holding! Nope this is soon to grow in value with awareness and unless a partnership (ONLY) is in hand like the good Dr. has mentioned than we are looking at the 10-15+ billion in a (partnership)with further validation, I don't care where we are sitting today!
imo
Tred
if the CC Missling is talking about is tied to that this would be the ULTIMATE trap for shorts! Go ahead, play with the stock price MONDAY! We will see how you like us on WEDNESDAY! Great feeling about the next two weeks. With the recent participation in the second "roundtable" I really think we have secured some kind of financing in the Cures Act. When does Obama Sign it? If Monday of Tuesday would this give Missling the GREEN LIGHT to announce whatever is in it?
OOOOHHHYAHHH BABY!
Tred
Good Morning All! I just took the time to contact either by phone or email 7 major alz, dementia care centers in CA with the CTAD in for on Anavex. Many of them may well be at the conference but incase they weren't, I figured I would expose them to the compelling science that is unfolding.
As I was typing I was not sure if this would ultimately be received, long term, as good news or not with many of them possibly having to change careers.
Oh well we need to GET THE NEWS OUT!
Good Luck and may God Bless all longs that have supported this company through thick and thin!
Tred
What happened, did the HFT machines BREAK? Are the MM's out of TRUE and ACTUAL shares? What happened to the volumne?
Certainly feels different going into this conference. I am looking forward to Saturdays long awaited PK PD data and Mondays market reaction.
Here's to 2-3 PR's next week!
Tred
I like those numbers NWDR! I like how conservative they are too with only %25 market penetration. This may take 4-5 years but with the right partner, with networks set up in the right countries, we are talking multiples of that....for just one indication!
I remember when Gild bought Pharm asset, they took a lot of heat from shareholders from the sticker price shock. Look how it has bloomed for Gild. I honestly believe if we can stay independent we have a much better chance of bringing the full potential of our pipeline to market and the FASTEST under Dr. Missling.
An interesting note on Pharmasset, Dr Ray Schinazi was a co inventor of their lead drug. Take a look at what he is doing over at Crystal with Dr. Frost and Teva. New best in class HPV drug!
http://ir.cocrystalpharma.com/press-releases/detail/30/cocrystal-announces-positive-interim-data-from-an-ongoing
Ticktockticktock
Tred
Neiu, I am not familiar with how these CTAD conferences roll. Are there Q&A sessions afterwards where she might provide updates on FDA "stuff"? Wouldn't this require an 8k if she were to announce or provide information? I am just wondering if there is any other reason to have her along besides the good ol' gaining "experience" factor.
I have to admit though, Missling is presenting in front of the right groups and getting sheate done in my book! The NIH and this other Gov. roundtable today are very good groups (with lots of ties to our money) to be kicking the can with, especially with a safe drug that has a unique mode of action! While I am not happy with the high 3's, I would MUCH rather have the stock price be where it is and have the momentum of "coming news" with a drug that works than be in Axon's position anyday! Even with FDA "FastTrack" for their (failed?) drug, I wouldn't touch that stock with a ten foot pole even if the street paid me. I watch it go up and then right back down. I can picture a hedge fund or two trading back and forth HOPING AND PRAYING for a small morsel from the FDA to bilk investors out of another BILLION or two.
Speaking of "FastTrack" status, so Biogens failed theory and Axovant failed plaque theory both receive FastTrack from FDA? Man its not like the FDA is desparate or anything is it? I mean come on, this is only Alz we are talking about. People's head swelling and falling out of trials and they are giving them incentives to "press" on. I am a firm believer that A 2-73 is going to be accepted early by the FDA with an ongoing trial to prove it out. JMHO!
Also, anyone know when the senate votes on the Cures Act?
Tred
I haven't seen this stock trade this low of volumne and sustain a pps in a long time! It would either pop on no news and run up just to crash down. Someone or something is getting ready to happen and perhaps has a few nervous to the point where the games have stopped,...for now.
#MAXED OUT on AVXL SHARES!
Tred
I agree MC. I think Dr. Missling just put his 9 millimeter away and upgraded to a rocket launcher! NO MORE BULLETS! We are going to launch "MISSLING MISSLES" at the cabal!
I hope Ariana has been able to play catch up and maybe even beyond 52 week. Makes one wonder if the FDA had any input with respect to Ariana and their FDA approved program. Say,.....With Anavex applying for Accelerated approval and the FDA saying "no not yet....but if you apply this and it shows up,...than!"
just sayin! There is a reason for the beautiful Ms. Capiak to be there in attendance!
Tred
Year over Year D. Missling has achieved quite a bit Imo. Look how far he has raised the bar not only with Alz trial but on MANY fronts. Its easy to sit back and drive from the back row but make no mistake, he IS in it to win! Would I have done a few things different? You bet, we all probably would have including Dr. Missling! IMO, in light of the fierce headwinds that the Pharma industry has thrown at us with bringing this kind of revelation of science to market, little ol' Annie has done just fine. Most companies would have been forced to sell half their remaining stock at pennies on the dollar just to get through ph2 a.......! Not the BRILLIANT Good Dr.!
I just cant get the slide in the spring presentation out of my mind. The one that shows A 2-73 in the middle and ALL the target indications around the circle with checkmarks by some. HE/WE ARE bringing those trials, for those indications, to light, and on a shoestring budget.
So as I wait for this week to pass, I am comforted in the thought that even with ALZ aside, WE HAVENT SEEN NOTHING YET! With the continued exposure that Anavex will get,.... there will be a giant SUCKING sound of companies, organizations, and gov.'s wanting to get in partnership with our little $4/sh company.
Tred
Multiple doses?
Maybe Opko Healths "CTE" technology it acquired when it bought Prolor would be of benefit. Dr. Frost has and is applying it to many things including vitamins and various drugs to keep them in the blood stream longer. I believe it extends the half-life by double in vitamins and drugs like Vitamin B called Niagen by Chromadex, Vitamin D called Rayaldee by Opko, HGH CTP (still in ph 3 trials) by Pfizer, and Niraparib by Tesaro. All are showing great confidence in results. Might be a WONDER DRUG in combo with A 3-71!
Maybe I will drop Good ol' Dr. Frost a line.
Tred
I agree MC. The fact that the graphs at 31 weeks showed improvement but management didn't support it is what confused shareholders and the "market". The line was there but no data! I believe its through additional time, Ariana and an improving graph has bolstered confidence by actually giving the FDA, Management, and possibly Dr. Perry the PROOF they needed. They see the patients getting better , they just couldn't prove it clinically yet.
Question, with two extensions why are patients still not on optimized dosage yet.
Optimistic that our CEO is going to fire MISSLING MISSLES at the market come Monday Dec. 12th.
locked and loaded
Tred
I'm not afraid to put a number on it.
100 shares bought today IMHO, based on research done on BIIB, CELG, REGN, etc....who started out with one drug for ONE indication, we as shareholders after accelerated approval in 1-2 years can expect a 2 for split for 5 consecutive years in a row, MINUMIM!, for just ALZ! This in MY opinion puts us with partnership at a valuation for the 100 shares in 7 years at a conservatively priced $50,000 and in as high of $300,000. Now if all those 2017 Phase 2 trials, with Ariana's FDA approved algorithmic program, continue to show a clean safety record, one can possibly assume that in possibly in 5-7 years we are all taking A 2-73 for a "maintenance" drug to prevent one indication or another, you can multiply that high price time 3. Minimum merge of 1 for 1 with Biogen but I agree if we can truly stay independent per Misslings early communicated path, we are going to be able to BUY Biogen!
WORD!
Tred
"It'll probably take a year just to find and enroll 300+ patients into the trial"
Really? They have been "underway on a phase 2/3 now for months. Maybe the anecdotal evidence that came out in the AU press at the nine month mark was to draw in a sizeable pool for the phase 3 selection. I doubt after seeing the evidence, approving not 1 but 2 EXTENSIONS that they have been sitting on their hands!
I agree that the AU will be the first to approve A 2-73 through an accelerated program due to safety and efficacy.
Tred
Exactly Drv,....I for one wonder how t!he Good Dr. sleeps at night or when the bodyguards will start driving Dr. Missling around! With his position and leadership skills so far he HAS to be tired of tiptoeing around the "game". Something is going to change and maybe......for this drug to progress a merger makes the most sense. I for one do not agree with the 1-1.5 Bil Buyout. We and I believe Missling are talking about the 10 Bil or 1 for 1 share of Biogen in a year or less! Hell, look at the 3 Billion for Heptares for a phase 1b,... A PHASE 1b! We HAVE THE BASES LOADED! Whats that worth?NOT BILLION!
May God Bless Dr. Missling, and the entire management team and may the Holy Spirit guide him for the rest of their days.
Tred
I strongly concur MC!
"Didn't 21 st Centurt Act just pass?
Didn't the good Dr just say in his last press release that he is trying to get A2-73 to market quickly?"
With the Cures Act throwing Billions at brain science, and recently Missling and Co. being recently invited to yet another "roundtable" for mental health,....I just don't see how it takes this drug 10 years. With the NON issue with respect to side effects, its my belief they are going to fund either through our gov., and or MULTIPLE private avenues (like we are seeing)and thousands of patients will be taking this drug for many trials in 2017. The amount of data compiled to date will be dwarfed by the accumulation and processing with Ariana THE " ....multiple phase 2 trials in 2017" and or phase 3's! If Ariana is able to find "common ground" in biomarkers in multiple trials for multiple diseases, I think it cuts the time down to 5 years or under when we ALL can take this drug for SOMETHING to prevent just about possibly EVERYTHING.
Who knows this may help Donald to help right the Debt Ship or at least all but guarantee (with Gov. funded trials)some serious FUTURE healthcare spending cuts.
Tred
Hi Mc.
Yes I think we see an increase in mono therapy with the difference in the points on the charts and if nothing else the side affects alone of dual therapy. This had to be offered at some point to the entire group after the 31 week results (26+5). I wonder if this is the reason for the 5 week change in the trial dates, (new 36) to have a 5 week "transition" period.
I can just see the groups getting together over coffee one day and the conversation going along the lines of ...(Don + A2-73) " so what have you been up to lately?" (Mono) "Ohhh not much just trying to lower my handicap in my golf game" or "yeah, lately I'm enjoying making my solo trips to the store once a week when I need groceries". At some point these SUPER 7 have have to surface in the media again. When will Anavex let them? Will they show up at a conference during the Q and A and start answering questions from the audience with a piano playing in the background? LOL
Also, on another note I remember after the last two conf. dumps how frustrated shareholders were with management and I recall there being some correspondence back and forth with IR regarding this. Basically it was conveyed that there was differing views on just what the best strategy was to deal with this. I believe the good Dr. is ready this time and is going to serve the manipulators a nice big piece of dung pie.....warm!
Not much room to go down but skies the limit to go up in the next 30 days, Imo.
Tred
Its my opinion (and my guts too,....in between beers)that we are in for some FDA news. Why else would Christine M. Kapiak be attending? I remember when she got her promotion to V.P. and it was soon after that the (2)orphan drug designations came out for A 2-73 and (1) 3-71. Its been quiet for some time now and I get the sneaky suspicion that with Ariana coming on board that Dr. Missling may have indeed found the "mined" data he needed to support the monotherapy patients response. Correct me if I'm wrong but wasn't the painter, pianoist, and golfer's anecdotal evidence all at or around the "9 month" mark when they were interviewed? It was there for the FDA and the good Dr. to see,..... they just couldn't share it or didn't have anything to support it because they were all in a 7 person subgroup. I'm going out on a limb and saying that we get:
1)41 week data and possibly 52 week data with Ariana's involvement.
2)some form of FDA Fasttrack or accelerated approval through or in combination with a grant from the 2017 Cures ACT for a Phase 2/3 for ALZ.
3)Parkinsons news before or right after the CTAD conference.
4)Possibly a funding mechanism for PTSD and Dementia also from the Cures Act.(providing the cures act is funded)
IF Ariana's FDA approved algorithm is fast in finding bio markers, I'm wondering just how far have they caught up in their analyzing of data as some of the patients are now entering 2 years on this drug. You never know, that subgroup the SUPER 7 may be running marathons in the "downunder"!
Goodday Mate!
Tred
A BIG Thank You to all who have contributed here since the yahoodlum board went awol a year or so ago! I have had a hard time with Ihub in getting my old account back since my first Verizon account "migrated" to Frontier networks. Lost everything!
Anyhoo has anyone heard whether or not the NIH approved the funding for the 2017 Cures Act? I googled NIH Funding 2017 and this is what I got.
https://niaprodfiles.s3.amazonaws.com/s3fs-public/reaching-for-a-cure-alzheimers-disease-and-related-dementias-research-at-nih.pdf
I found this tidbit rather interesting. Isnt this in the neighborhood of about what our small Phase 2/3 trial would cost?
"NIH proposes that an additional investment of $323 million will be needed in FY 2017."
AHH soo GOOD to post again! GO ANAVEX!
Tred
The old CFO (Cunning)ham should be listed as well. Hell, he sold for $4.00 plus when he left. He was the only smart rat of the bunch jumping ship well before the bow started to list. I also cant understand why Bly relied on Berooze so heavy as a money raiser when he wasnt legally licensed to do so per the S.E.C. In the old BK(1990?), it clearly states that he was NOT to be listed as a "financier" in financially pulling TIV out of BK (paraphrasing). Once they were clear from BK, he goes back to his old ways of selling (scamming) people (opis?) out of subscriptions in oil "plays"? And why was he posting(Hyping) on messageboards like Silicon investor and yahoodlums when he was supposedly a main guy responsible for raising money,....for YEARS? Like I said before, get the 5 or 6 of the main EARLY Opus investors (as well as the old Ceo and CFO's)in front of a firing squad and get to the bottom fast. I personally wouldnt wait on the S.E.C.. They have their hands full with the Morgans, Lehmans, and Goldmans. Bly and BEROOZ look like bar flies compared to them.
Tred
Well said JD! I am one of those that lost many thousands in TIV believing many hyped stories from PR's, Opus insiders/money raisers, and video's (from investors)with property photo's displaying Tiv's logo at the beginning of each video. Yes it turned our to be quite the pyramid scheme in my humblest of opinions. The fact was that many opus investors brought in their friends who in return brought in friends of friends, relatives of friends, street corner bakers, massuse's, asphalt layers, groundskeepers,...... and any one else that could be sucked in. When each new "project financing" came through from the "money raiser"(turned out he was breaking the law), the same amount invested in "projects" needed to be bought in stock on the open market. This was the mechanism that created the "bagholder" effect allowing hundreds if not thousands over the years to lose hundred of thousands if not millions of dollars over the decade. All you had to do was play the "pops" and sell into the hype, short it back down and margin account it back up. Was inside info disementated? I don't know but the former CEO is currently being investigated by the S.E.C. for insider trading so you take a guess. Must be how the racket is run on stocks. Pretty cheap lesson I have learned but would love to see those involved see jail time.
In the end I jumped my few thousand over to MUX at 2.78 and that my friend is THE ONLY silver lining to this story. Please post if anyone hears about anymore cases brought against TIV's managemant.
Underwater too!
Has anyone heard any "little birdie" chirps about:
1)the S.E.C investigation
2)opus agreement
3)whether Cunningham,....and for that matter beyrooze as well, are still in the AMERICA'S! lol
TIA
TRED
The only positive I took away from TIV was when I finally pulled my head from my azz and jumped ship at mostly .08,then .07, and finally .05. My money is now in MUX with an average of 2.68 so timing was great. I often wondered if the early claflin was merely a smokescreen for the later "we tried but somehow couldnt make it work" excuse. I notice in investor village how the moderator "timberwolf" was frustrated (when claflin financing was being rounded up) with management for not ever responding to his request for partnership financing, now I think we know why. I myself think it was planned from the get go by ALL! We will have to see how the (pu) S.E'.C. investigation turns out.
refuse to visit yabahoodlum board again
TRED
If the S.E.C. simply looks at who bought "feverishly" 1-2 days before the P.R.'s (from the old regime)came out, and then sold ALL or MOST of their shares knowing no news would come out for another 3 months, they would have their hands full for the remainder of this year alone, imho. I watched time and time again thinking that once, JUST ONCE there would be news actually supporting the wild fluctuations of stock being bought and sold. Nope! I was definitely wrong! The sad part is the use of the message boards. They are all, in and of themselves, enough to drive any legally sane person right over the edge. The fact that "certain individuals" (with purportedly insider info) were possibly using them to enhance the "pump and dumps" only adds salt to the wounds of hundreds if not thousands (over 10 years?) of investors affected. Yeah, yeah, yeah!... thats what you get for investing in "wildcatting" penny stock wanna-be 50 year old oil companies. Bullshoot!
If this management has ALL shareholders BEST INTERESTS in mind, they should take this "black eye" (S.E.C. investigation) and make it into a positive by cleaning out the closets COMPLETELY!
jmho
TRED
"IMO...I suspect TIV wouldn't waste a moment reading discussion boards, let alone comment on them."
Maybe not this management but Lynn was VERY aware of the messageboard forums and the level with which they could/were used. He acknowledge them publicly in a Annual shareholders meeting about the time Bell walked out the door.
In another instance he had the gall to reply back to me from an email I sent him regarding the total lack of results and consequently the pps plummeting,......." do you post on messageboards?" LOL, SERIOUSLY, that was all he replied! So at least he read many of the comments made on the forums and was fully aware of their value.
Opis trading records (very few,not all) with respect to timing of P.R. announcements will be the "straw", IMHO.
TRED
I've heard of at least one of those stories about inter-office memo's being passed around and someone buying time saying "we're almost there, just a little bit longer". In my opinion, if this isnt just a "surface inquiry" or technicality to allow the opis deal to proceed than it WILL (and trust me HAS had) have very long reaching effects on MANY investors. I personally am not going anywhere until I see Tiv with a profit or guilty parties brought forward. I've often wondered if some(not all) in opis were "funding" partnerships with "profits" (some called it losses)form stock sales on insider tips.
Of course I hope Tiv pulls out from under this dark cloud and the many others but it never fails, nothing but constant bad news and then long periods of silence are all that surrounds the P.R. machine lately.
jhmo and two cents worth
TRED